- cross-posted to:
- world@quokk.au
- world@quokk.au
- cross-posted to:
- world@quokk.au
- world@quokk.au
Weight-loss jabs such as Wegovy could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as patents expire.
More than a billion people live with obesity worldwide, with rates rising fast in lower-income nations as they shift to westernised diets and more sedentary lifestyles.
The World Health Organization designated semaglutide – sold to treat obesity under the brand name Wegovy, and diabetes under the brand name Ozempic – as an essential medicine in September last year.
But global health leaders warned at the time that high prices were limiting access.
New research, published as a pre-print, suggests that semaglutide could be mass produced for $3 (about £2.35) for a monthly dose in its injectable form.
Man the corporate agro-industrial complex must be so excited about how the corporate pharmaceutical complex is pioneering for a humanity with limitless tolerance to fat and sugar. The shareholders will be delighted!
This drug does the opposite. It reduces appetites so people eat less.
Uhmmm … that’s not how it works. It halts your fat and sugar absorbtion … “tolerance” is not the word I would use to describe getting the screaming shits after eating too much fat and sugar.
The main feature is the appetite suppression … that is VERY real.